0001213900-20-027391.txt : 20200918 0001213900-20-027391.hdr.sgml : 20200918 20200918170125 ACCESSION NUMBER: 0001213900-20-027391 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200916 FILED AS OF DATE: 20200918 DATE AS OF CHANGE: 20200918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linscott Walt Addison CENTRAL INDEX KEY: 0001648585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37521 FILM NUMBER: 201184561 MAIL ADDRESS: STREET 1: 1860 MONTREAL ROAD CITY: TUCKER STATE: GA ZIP: 30084 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intec Pharma Ltd. CENTRAL INDEX KEY: 0001638381 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 BUSINESS PHONE: 97225864657 MAIL ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 4 1 ownership.xml X0306 4 2020-09-16 0 0001638381 Intec Pharma Ltd. NTEC 0001648585 Linscott Walt Addison C/O INTEC PHARMA LTD. 12 HARTOM STREET JERUSALEM L3 9777512 ISRAEL 0 1 0 0 Chief Business Officer Stock Option (right to buy) 0.3215 2020-09-16 4 A 0 100000 0 A 2027-09-16 Ordinary Shares 100000 100000 D The stock option vests and becomes exercisable in full on December 31, 2021. /s/ Walt Linscott 2020-09-18